LRB-4530/1
MED:cdc
2019 - 2020 LEGISLATURE
December 5, 2019 - Introduced by Representatives Nygren, Born, Novak, Snyder,
Petersen, Kitchens, Quinn, Felzkowski, Edming, Kulp, Magnafici, Plumer,
Horlacher, Rohrkaste, Knodl, Tusler, Petryk, Dittrich, Tranel,
Thiesfeldt, Jagler, Spiros, Mursau, Ramthun, Billings and Bowen,
cosponsored by Senators Kooyenga, Cowles and Wanggaard. Referred to
Committee on Health.
AB649,1,3
1An Act to amend 227.01 (13) (zk); and
to create 448.039 of the statutes;
2relating to: guidelines regarding the treatment of neonatal abstinence
3syndrome.
Analysis by the Legislative Reference Bureau
This bill requires the Medical Examining Board to issue guidelines regarding
best practices for the treatment of neonatal abstinence syndrome, a condition that
may occur in a newborn following the discontinuation of fetal exposure to substances
that were used by the mother during pregnancy.
For further information see the state fiscal estimate, which will be printed as
an appendix to this bill.
The people of the state of Wisconsin, represented in senate and assembly, do
enact as follows:
AB649,1
4Section
1. 227.01 (13) (zk) of the statutes is amended to read:
AB649,1,55
227.01
(13) (zk) Are guidelines issued under s. 440.035 (2m) (b)
or 448.039.
AB649,2
6Section
2. 448.039 of the statutes is created to read:
AB649,2,4
7448.039 Neonatal abstinence syndrome guidelines. The board shall issue
8guidelines regarding best practices for the treatment of neonatal abstinence
1syndrome. In developing the guidelines under this section, the board shall consult
2with obstetricians and gynecologists, pediatricians, and relevant state associations
3to ensure that the guidelines are appropriate and reflective of evidence-based best
4practices for the treatment of neonatal abstinence syndrome.
